ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, ANI Pharmaceuticals, Inc. (ANIP) shows an Average True Range (ATR) of 2.02 and an Enterprise Value of 1.47B. Its average trading volume over the past 3 months is 352.05K, indicating liquidity. These fundamental metrics provide insight into ANIP's underlying financial health and market activity.
ANI Pharmaceuticals, Inc. (ANIP) technical indicators as of July 23, 2025: the SMA 20 is 1.15%, SMA 50 at 5.17%, and SMA 200 at 8.6%. The RSI 14 value is 54.79, suggesting its current momentum. These technical analysis signals help assess ANIP's price trends and potential future movements.
ANI Pharmaceuticals, Inc. (ANIP) stock performance overview as of July 23, 2025: The 52-week high is $77 (currently -13.84% below), and the 52-week low is $52.5 (currently 26.36% above). Over the past year, ANIP's performance is 5.34%, compared to the S&P 500's 13.39% change.
According to market data, ANI Pharmaceuticals, Inc. (ANIP) stock's recent performance metrics show that over the last month, ANIP is 1.19%, with a Year-to-Date (YTD) performance of 20.01%. Over the past year, the stock has seen a 5.34% change. These figures summarize ANIP's price movements across various periods, reflecting its historical returns.
According to current financial data, ANIP stock's P/E (TTM) ratio is -61.64, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ANIP, including P/S (2.13), P/B (3.10), and P/FCF (20.95), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.